More than 10,000 chemicals used in everyday items such as nonstick pans and stainproof carpets could face new limits across the European Union after an expert committee backed EU-wide action on PFAS, often called “forever chemicals.” The chemicals can persist in the environment and have been found contaminating food, water and wildlife.
The European Chemicals Agency (ECHA) announced Thursday that its Committee for Socio-Economic Analysis, known as SEAC, had adopted its final opinion supporting restrictions. The committee said EU-wide rules are needed to address PFAS risks, prevent different national rules from distorting the market and keep businesses on a level playing field across the bloc.
SEAC supports a ban with exceptions tailored to particular uses, taking account of the costs and benefits of restrictions. Its opinion follows an assessment by ECHA’s Committee for Risk Assessment, or RAC. Both committees say current rules are not enough to control PFAS emissions and risks, and that further action across the EU is needed.
The health concerns are significant. Long-term exposure, even at low levels, has been linked to liver damage, high cholesterol, weaker immune responses, low birth weights and several kinds of cancer. RAC experts have argued that a complete ban would be the most effective way to reduce harm, warning that exemptions could allow continued emissions and leave risks uncontrolled.
The committee’s backing is an important step, but it is not yet a law. The European Commission can now prepare a proposal for restrictions across the bloc, which is expected in early 2027. The EU has said it wants to ban PFAS in everyday consumer goods such as clothing and pizza boxes, while allowing exemptions for areas considered critical, including defense and health care.
Environmental groups are urging the Commission to make the rules broad. Amelie Ott, a senior policy officer at the European Environmental Bureau, said the Commission should follow the independent experts’ advice and allow only specific, time-limited exceptions for essential uses where alternatives are not available. She said urgent action is needed to reduce PFAS impacts on people, the economy and the environment.
The debate is also drawing strong industry pressure. Pharmaceutical lobby EFPIA has warned that companies could move production abroad without clear, lasting exceptions for medicines. German industry group Spectaris has defended fluoropolymers, a type of PFAS material used in medical devices and other high-tech equipment. Companies in aerospace, solar panels and cars are also among those seeking exemptions.
With the Commission’s proposal still ahead, the challenge will be to reduce pollution while deciding which uses, if any, truly need an exception. The expert committees’ shared conclusion is that existing measures fall short; the next decision will determine how far a common European response goes.
